In this Huberman Lab Essentials episode, I explain how the neurochemicals epinephrine, acetylcholine and dopamine contribute to focus and concentration. I discuss tools for improving attention, including sleep, sound, structured work sessions, nutrition, caffeine and deliberate cold exposure. I also describe a brief daily meditation and visual focus exercises that train your ability to refocus when attention drifts. Additionally, I discuss the potential benefits and limitations of supplements,

Neuroscience Daily for 08 October follows 3 stories from r/neuro and r/neuroscience, moving through optogenetics nobel, dopamine reward signals, social pain codes.Chapters 00:00:00 — Intro 00:00:11 — Optogenetics Nobel 00:01:12 — Dopamine Reward Signals 00:02:06 — Social Pain Codes 00:03:01 — Closing 1. Optogenetics Nobel Beezloop reports that a Stanford psychiatrist is sharing the Nobel Prize in Medicine for work that helped turn light into a way of controlling brain cells. The

Hey! I'd love to hear your thoughts, send me a voice note.Dr. Toll is the founder of Compassion Neuroscience, where he combines TMS with neuroimaging methods such as EEG to treat patients with depression, anxiety, PTSD, and OCD. His evidence-based approach emphasizes quantitative measures to enhance patient outcomes and expand access to care—particularly for Gold Star families. Dr. Toll earned his PhD in Bioengineering from Stanford, specializing in TMS, EEG, and MRI. A West Point graduate, he

Michael speaks with Brady Holmer, the exercise scientist and 2:24 marathoner behind the Substack Physiologically Speaking, about which fitness trends hold up. Brady explains why he stopped taking creatine, which numbers on your wearable to ignore, and why endurance athletes now eat the carbs of three Cokes an hour. They discuss:(00:00) Preview(00:35) Why Brady stopped taking creatine(03:26) Creatine is oversold for the brain(09:14) The wearable numbers to ignore(12:47) The problem with HRV(16:14)

In this episode of Denatured, you’ll hear from Max Bronstein, CEO of Aviva Strategies and Teresa Barnes, Chief Executive Warrior of PF Warriors. We dig into why U.S. patients are losing access to rare disease trials happening abroad and how the FAIR Act’s accelerated, harmonized reviews could help the U.S. keep pace while getting lifesaving studies to patients faster.Host⁠Jennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsMax Bronstein, CEO, Aviva StrategiesTeresa Barnes, Chief Executive

Pharma 2035: The Evolution to Autonomous Intelligence The pharmaceutical industry is known for cutting-edge science, precision, and highly regulated operations. Yet behind the sophistication of modern therapies, many manufacturing environments still depend on fragmented systems, manual processes, siloed data, and reactive quality management. This episode explores how pharma can move beyond traditional automation toward a fundamentally different operating model: autonomous, intelligent, connected,

This episode explores genetic service delivery and various ways genetic counseling can be incorporated.Segment 1: How to Reduce Time to Genetic Testing: A Video-Based Approach in the Inherited Cardiac Conditions Service Guest Bios Dr Lisa Bryson is a Clinical Genetics Registrar at the Centre for Genomic Medicine in Glasgow, with a background in paediatrics. She is due to complete her clinical genetics training shortly and will take up a Consultant Clinical Geneticist post in New Zealand. She

Ever wonder what the hosts of AJIC do in their free time? Join 5 Second Rule Podcast hosts, Kelly Holmes and Jess Fargher, as they flip the script on Nikki Shore and Jessica Swain, the dynamic duo from "AJIC Science into Practice." In this episode, they explore their unique journeys into infection prevention, share memorable podcast moments, and discuss how humor and personal stories shape their discussions. Get ready for insights, laughter, and a deeper understanding of the science behind the mic!

Leadership Communication Skills | #leadershipcommunication #executivepresence #presentationskills In this episode of Biotech Bites, host Steve Swan talks with leadership communication expert Michael Piperno about how to improve the way you communicate in the boardroom, in presentations, and in interviews. Please visit our website to get more information: https://swangroup.net/ They break down real communication coaching tips, why executive presence matters, and how to connect with your audien...

Biotech founders often pour everything into building the “perfect” product only to realize their real customers have walked out the door. Chasing perfection can burn money and stall even the most promising CMC innovations. In this episode, David Brühlmann continues his conversation with biotech entrepreneur and investor John Bonham-Carter. John shares his insights on the realities of building and scaling successful biotools companies, from the challenges of fundraising and the importance of a...

Zhu et al., Proceedings of the National Academy of Sciences - Genome-wide studies of schizophrenia and other psychiatric disorders find hundreds of hits, yet those hits barely clear the significance threshold and tend to be common variants, unlike traits such as LDL cholesterol. This study shows that other traits whose heritability is enriched in the central nervous system share the same pattern, that the pattern survives careful matching of statistical

Zhu et al., Proceedings of the National Academy of Sciences - Genome-wide studies of schizophrenia and other psychiatric disorders find hundreds of hits, yet those hits barely clear the significance threshold and tend to be common variants, unlike traits such as LDL cholesterol. This study shows that other traits whose heritability is enriched in the central nervous system share the same pattern, that the pattern survives careful matching of statistical

What if you could switch between deep focus and true recovery on command, instead of white-knuckling one gear until you burn out?Serial entrepreneur and Organic Technology creator Hess Adnani joins Nick to map the human operating system: a two-axis model of your nervous system and your mind that tells you where you are and how to move. He explains why recovery is a productivity multiplier, not lost time, and how to read your body's free daily signals instead of leaning only on wearables and

Mechanisms broad enough to matter across many diseases, from mitochondrial health to the biology of aging, emerged as a defining theme at Grand Rounds Europe in Amsterdam. On a special live edition of the BioCentury This Week podcast, BioGeneration Ventures' Oskar Slotboom, NautaDutilh's Ruud Smits and Leyden Labs' Dinko Valerio join BioCentury's analysts to discuss women's health and sleep as lenses on disease, and the shift toward prevention. The panel also weighs the limits of "Frankenstei...

In this special Beyond Lab Walls video podcast episode—part of the Salk Institute's 2026 Year of Brain Health—Salk President Gerald Joyce, MD, PhD, sits down with Janelle Ayres, PhD, an expert on how the immune system helps the body maintain balance, recover from stress, and stay resilient across a lifetime.

In this episode of Flow Radio, hosts Steven Kotler and Dr. Michael Mannino sit down with neuroscientist Dr. Richard Huskey to ask a deceptively simple question: what is actually happening in the brain during flow?There's no flow neuron and no flow region. Drawing on their new NeuroImage paper and years of work in Huskey's lab, the three explore why flow isn't one part of the brain lighting up but the whole brain coordinating and breaking apart—the property neuroscientists call

What is the story of everything? Is there a scientific and philosophical basis for meaning? Today on ID The Future, host Andrew McDiarmid continues exploring those questions with physicist and author Dr. Eric Hedin. In Part 2, the conversation turns to the scientific and philosophical basis for meaning in the universe. Dr. Hedin argues that materialism "fails to describe the world we experience." He explores the problem with reducing life and the universe to their lowest terms. Sure, we boil down

How can Medical Affairs teams move faster, align global brand strategy, and use artificial intelligence (AI) while keeping patients first? Emad Siddiqui, Senior Vice President, Head of Medical Affairs Global Brand Strategy at Astellas Pharma, joins host Peg Crowley-Nowick on Medical Affairs Unscripted. A surgeon by training, Emad describes his move from clinical practice into Medical Affairs and his belief in putting patients and science first. He explains the Astellas "Brand at the Center" model,

We have a panel of technical and business leaders from Belimed Life Science on today's episode that includes Ricardo Santana, Markus Maier and Jochen Schlag. Ricardo is Belimed's Northeast sales manager in the USA and supports global capital project teams. Jochen is Belimed's head of business development and sustainability and helps life science companies with sustainable cleaning and sterilization solutions. Markus is a Product Manager for sterilizers, where he gives technical presentations, leads

Immune tackles papers on the breadth of human B cell responses following mRNA vaccination and on the role of mitochondria and reactive oxygen species in plasma B cell maintenance. Hosts: Vincent Racaniello, Cindy Leifer, Stephanie Langel, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of Immune! Links for this episode MicrobeTV Discord Server mRNA flu vaccine expands B cell breadth (Nat Immunol, 2026) Mitochondrial ROS and plasma cells (Nat Commun, 2026) Time